Literature DB >> 1798020

Studies on the transport pathway of PBCA nanoparticles in ocular tissues.

A Zimmer1, J Kreuter, J R Robinson.   

Abstract

The transport pathway of PBCA nanoparticles through the rabbit cornea and conjunctiva was studied using fluorescence microscopy. Nanoparticles were produced by an emulsion-polymerization process, purified by a GPC procedure, and labelled with rhodamine 6G or propidium iodide as fluorescent laser dyes. The stability of the dye label, particle diameter, and zeta potential of the nanoparticles were determined. Freshly excised rabbit cornea and conjunctiva were incubated with a suspension of labelled nanoparticles for about 30 min in standard perfusion cells. After incubation the particles were visualized, due to their fluorescent character, using laser scanning confocal microscopy. The results show a fluorescence signal inside the cells. In particular conjunctival cells showed an uptake of nanoparticles. Fluorescent particles were visually observed inside the cells, in what appeared to be vesicles or granules. Thus, either endocytosis of the nanoparticles by conjunctival tissue or lysis of the cell wall by nanoparticle metabolic degradation products, are possible explanations of the data. A fluorescence signal was also observed within corneal cells. Only a transcellular pathway was observed. A possible penetration through tight junctions was not noticed; moreover, penetration was observed only into the first two cell layers and no full tissue penetration occurred.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1798020     DOI: 10.3109/02652049109021873

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  9 in total

1.  Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A.

Authors:  P Calvo; A Sanchez; J Martinez; M I Lopez; M Calonge; J C Pastor; M J Alonso
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

2.  Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol.

Authors:  C Losa; L Marchal-Heussler; F Orallo; J L Vila Jato; M J Alonso
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

Review 3.  Nanoparticles for drug delivery to the anterior segment of the eye.

Authors:  Dileep R Janagam; Linfeng Wu; Tao L Lowe
Journal:  Adv Drug Deliv Rev       Date:  2017-04-06       Impact factor: 15.470

4.  Evaluation of poly(isobutylcyanoacrylate) nanoparticles for mucoadhesive ocular drug delivery. I. Effect of formulation variables on physicochemical characteristics of nanoparticles.

Authors:  S K Das; I G Tucker; D J Hill; N Ganguly
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

5.  The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers.

Authors:  Mohamed G Qaddoumi; Hideo Ueda; Johnny Yang; Jasmine Davda; Vinod Labhasetwar; Vincent H L Lee
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

6.  Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system.

Authors:  A Zimmer; E Mutschler; G Lambrecht; D Mayer; J Kreuter
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

7.  Engineered nanomaterials: exposures, hazards, and risk prevention.

Authors:  Robert A Yokel; Robert C Macphail
Journal:  J Occup Med Toxicol       Date:  2011-03-21       Impact factor: 2.646

Review 8.  An overview on dry eye treatment: approaches for cyclosporin a delivery.

Authors:  Burçin Yavuz; Sibel Bozdağ Pehlivan; Nurşen Unlü
Journal:  ScientificWorldJournal       Date:  2012-04-24

Review 9.  Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.

Authors:  Rinda Devi Bachu; Pallabitha Chowdhury; Zahraa H F Al-Saedi; Pradeep K Karla; Sai H S Boddu
Journal:  Pharmaceutics       Date:  2018-02-27       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.